Bionano Genomics Inc. logo

Bionano Genomics Inc.

BNGO | NASDAQ
Chart Builder DCF Calculator
$1.83
+$0.10 (+5.78%)
At close: Sep 21, 2026, 4:00 PM ET
$1.87
+$0.04 (+2.19%)
After-hours: Sep 21, 2026, 7:56 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-26.4M -112.02M -232.49M -132.6M -72.44M -41.11M
Depreciation & Amortization
9.73M 14.23M 13.91M 9.84M 3.37M 1.48M
Stock-Based Compensation
4.53M 9.74M 15.18M 22.42M 9.72M 1.55M
Other Working Capital
-2.58M 4.27M -6.33M -3.96M 1.99M 484K
Other Non-Cash Items
-4.73M 14.73M 92.99M 1.7M 848K 3.2M
Deferred Income Tax
n/a n/a n/a 1.76M -5.78M n/a
Change in Working Capital
514K 4.4M -14.77M -27.94M -7.65M -3.44M
Operating Cash Flow
-16.35M -68.92M -125.18M -124.82M -71.93M -38.31M
Capital Expenditures
n/a -103K -1.69M -3.3M -1.46M n/a
Cash Acquisitions
n/a n/a 96K -31.34M -49.09M -2.45M
Purchase of Investments
-241.88M -233.02M -111.26M -84.2M -313.39M n/a
Sales Maturities Of Investments
229.13M 306.96M 137.02M 200.89M 86.48M n/a
Other Investing Acitivies
n/a n/a n/a 618K -607K n/a
Investing Cash Flow
-12.75M 73.84M 24.16M 82.77M -278.06M -2.45M
Debt Repayment
-4.95M -48.06M 70.95M -36K -15.01M -4.72M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -10.06M -14.84M -85K 8.41M 26.69M
Financial Cash Flow
24.04M -13.69M 113.82M 23.01M 336.11M 61.9M
Net Cash Flow
-5.06M -8.78M 12.86M -19.08M -13.88M 21.14M
Free Cash Flow
-16.35M -69.03M -126.87M -128.12M -73.39M -38.31M
Adj. Free Cash Flow
-20.88M -78.76M -142.05M -150.54M -83.11M -39.87M
Maintenance CapEx
n/a -103K n/a n/a n/a n/a
Growth CapEx
n/a n/a -1.69M -3.3M -1.46M n/a
Owner Earnings
-16.35M -69.03M -125.18M -124.82M -71.93M -38.31M

© 2026 bestshares.com. All rights reserved.